GPCRs-Targeted Drug Discovery Summit Leaderboard
  • Monday, May 11, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Obesity & Weight Loss Drug Development Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 300

Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)

Jan 3, 2022
Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced that it has completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG), a premier…
Read More...

Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition

Jan 3, 2022
Novo Nordisk announced that the acquisition of Dicerna Pharmaceuticals, Inc. announced on 18 November 2021, has been completed. Following the expiration of Novo Nordisk’s cash tender…
Read More...

Ionis and AstraZeneca close deal to develop and commercialize eplontersen

Jan 3, 2022
Ionis Pharmaceuticals, Inc. announced the closing of the collaboration agreement with AstraZeneca to develop and commercialize eplontersen, Ionis' investigational antisense medicine for…
Read More...

Amphastar Receives FDA Tentative Approval for Vasopressin

Jan 3, 2022
Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has tentatively approved the Company's Abbreviated New Drug Application for Vasopressin injection,…
Read More...

Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral…

Jan 3, 2022
Ascletis Pharma Inc. announces the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2 infection. The…
Read More...

Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment…

Jan 3, 2022
Merck known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization…
Read More...

Advancing AI Drug Discovery in Clinical Trials at SMi’s 3rd Annual AI in Drug Discovery Conference

Dec 20, 2021
SMi Group reports: Scientists to join 3rd Annual AI in Drug Discovery Conference to learn about the breakthroughs in clinical trials in ai drug discovery SMi’s 3rd Annual AI in Drug…
Read More...

Exploring the Impact of Machine Learning and Artificial Intelligence in Drug Development from…

Dec 20, 2021
SMi Group reports: the 3rd Annual AI in Drug Discovery is set to return to London in March 2022 with a key focus on the opportunities of machine learning and AI in drug development…
Read More...

The Transdermal and Microneedle Drug Delivery Conference 2022 is now a Virtual Event: Online Access…

Dec 20, 2021
SMi Reports: Event Announcement: Transdermal and Microneedle Drug Delivery, January 12-13th January 2021 is now a virtual event. Access will be fully online meaning therefore…
Read More...

SMi’s 10th Annual Pharmaceutical Microbiology UK Conference – A Virtual Conference with Online…

Dec 20, 2021
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only…
Read More...
Previous 1 … 298 299 300 301 302 … 924 Next
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
GPCRs-Targeted Drug Discovery Summit
5th World ADC Summit South Korea
Extrahepatic Lipid-Based Nanoparticles Delivery Summit
World TPD & Induced Proximity Summit South Korea
Measuring Patient Engagement Summit
Investigative & Preclinical Toxicology Summit 2026
LEAP HR: Life Sciences West
Oligonucleotides for CNS Summit
R&D Procurement & Sourcing in Pharma Summit
In Vivo Cell Engineering & Gene Editing Summit
PFS & Injectable Drug Delivery West Coast
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
World Bispecific & T-Cell Engager Summit South Korea
TCR-Based Therapies Summit
PFS & Injectable Drug Devices East Coast
5th ADC Analytical Development Summit
Nasal Formulation & Delivery Summit
Peptide-Based Therapeutics Summit 2026
ALS Drug Development Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Roche Acquires PathAI to Expand Digital Pathology Business
  • Altasciences, Certara Partner to Speed Early Drug Development
  • Angelini Pharma to Acquire Catalyst in $4.1 Billion Deal
  • Novartis Breaks Ground on Texas Cancer Therapy Facility
  • Lilly Expands Indiana Manufacturing With $4.5 Billion Investment

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

Turning Biophysical Data into Confident Drug Discovery…

Targeted LNP Delivery Beyond the Liver: The Challenges…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.